Speaker illustration

Doctor Jelle Caspar Lorenz Himmelreich

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

Member of:

European Society of Cardiology

Comparing Rivaroxaban and Apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria

Event: ESC Congress 2021 - The Digital Experience

Topic: Oral Anticoagulation

Session: Atrial fibrillation e-posters

Thumbnail

Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Oral Anticoagulation

Session: Atrial fibrillation e-posters

Thumbnail

Identifying patients at risk for atrial fibrillation in the community: a systematic review and meta-analysis of prediction models

Event: ESC Congress 2019

Topic: Scores

Session: Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

Thumbnail

Premature atrial contractions are associated with atrial fibrillation, brain ischemia, and mortality: a systematic review and meta-analysis

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation - Detection, treatment, outcomes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb